Seelos Therapeutics, Inc. | TalkMarkets

Latest Posts

6 Largest Psychedelic Compound-Based R & D Stocks Up 4%, On Average, Last Week

Article By: Lorimer Wilson

Tuesday, September 5, 2023 9:14 AM EDT

The 6 psychedelic compound-based research & development stocks in our munKNEE Psychedelic Drug Stocks Index were UP 3.9%, on average, last week and are now only UP 9.4% YTD.

In this article: ATAI, MNMD, CMPS, SEEL, GHRS, IXHL, PSIL

Read

6 Largest Psychedelic Compound-Based R&D Stocks Continued Downwards, On Average, This Week

Article By: Lorimer Wilson

Friday, August 25, 2023 7:49 PM EDT

Only 2 of the 6 psychedelic compound-based research & development stocks in our Psychedelic Drug Stocks Index were up this week.

In this article: ATAI, MNMD, CMPS, SEEL, IXHL

Read

May Summary Of Largest Psychedelic Compound-Based Drug Stock Performances

Article By: Lorimer Wilson

Thursday, June 1, 2023 4:14 PM EDT

Only two of the seven largest psychedelic compound-based drug stocks tracked, advanced in May.

In this article: ATAI, MNMD, CMPS, SEEL, GHRS, IXHL, CYBN

Read

6 Largest Psychedelic Stocks Showing Strength; Up 11.5% YTD

Article By: Lorimer Wilson

Friday, February 17, 2023 4:52 PM EDT

A look at the performance of the six largest psychedelic stocks by market capitalization.

In this article: ATAI, MNMD, CMPS, SEEL, GHRS, CYBN

Read

The "Multi-Bagger" Portfolio Continued To Outperform The S&P 500 Last Week

Article By: Lorimer Wilson

Tuesday, February 7, 2023 1:09 AM EDT

Our basket of mostly microcap cannabis, psychedelic and plant-based food stocks was extremely oversold in 2022 but we're watching for them to bounce back in 2023.

In this article: AAWH, MNMD, ACB, OGI, JUSHF, ACRDF, TTCF, SEEL, CYBN

Read

All Posts